Notice Information
Notice Title
A multi-drug resistant pathogen reference strain and clinical isolate collection
Notice Description
A multi-drug resistant pathogen reference strain and clinical isolate collection representative of pathogens and resistance mechanisms directly aligned to the PACE first funding call that can be used by the provider to generate antimicrobial susceptibility data across PACE-funded projects and that can be made available to PACE awardees for onward project progression. Continued expansion and characterisation of the strain and isolate collection to ensure it remains reflective of contemporary and genomically diverse multi-drug resistant and epidemic lineages of target pathogens (~20-30 strains) across E. coli, K. pneumoniae, P. aeruginosa, A. baumannii and S. aureus. This expanded collection will be made available for antimicrobial susceptibility testing (AST) across PACE-funded projects and the wider AMR community.
Lot Information
Lot 1
The UKHSA are well positioned to provide the services required by PACE for PACE portfolio funded projects and the wider AMR community. This will include but not be limited to the following: AST against a well characterised (including phenotypically, whole-genome sequenced with full antibiogram data) set of isolates and strains directly relevant to the PACE funding call, and; AST data delivered according to industry standards, and; Provided in an open-access environment, enabling PACE awardees to directly learn from and access the lab capability provided for onward studies, and; An opportunity to transfer specific isolates to PACE awardee labs for onward studies, and; The isolate bank will be evolved using the latest surveillance and national reference laboratory data on clinical isolates currently circulating nationally and internationally, and; UKHSA AMR labs then enable rapid characterisation of new isolates including full antibiogram and whole genome sequencing, and; A service model that can account for diverse needs of the PACE-funded projects as they arise i.e. variations to SOPs as required and ability to provide rapid surge capacity as and when needed.
Procurement Information
Following the voluntary ex ante transparency (VEAT) notice previously published, indicating that Medicines Discovery Catapult, intends to enter into a contract with the UK Health Security Agency (UKHSA) for a multi-drug resistant pathogen reference strain and clinical isolate collection without a call to competition in accordance with the Public Contracts Regulations 2015 ((32.2(b) ii), Medicines Discovery Catapult has now entered into the contract with UKHSA. The contract is directly aligned to the PACE (Pathways to Antimicrobial Clinical Efficacy) first funding call that can be used by the provider to generate antimicrobial susceptibility data across PACE-funded projects and that can be made available to PACE awardees for onward project progression and will allow continued expansion and characterisation of the strain and isolate collection to ensure it remains reflective of contemporary and genomically diverse multi-drug resistant and epidemic lineages of target pathogens (~20-30 strains) across E. coli, K. pneumoniae, P. aeruginosa, A. baumannii and S. aureus. This expanded collection will be made available for antimicrobial susceptibility testing (AST) across PACE-funded projects and the wider AMR community. The UKHSA maintains unique capabilities and assets that are part of the country's critical national infrastructure to support this aim, this includes; The English surveillance programme for antimicrobial utilisation and resistance (ESPAUR), which identifies emergence and trends in key resistance-causing pathogens. The AMRHAI (antimicrobial resistance and healthcare associated infections) national reference unit, part of the Bacteriology reference department (BRD) - a national and international laboratory reference centre for a bacterial infections. The isolate bank will be evolved using the latest surveillance and national reference laboratory data on clinical isolates currently circulating nationally and internationally and; UKHSA AMR labs then enable rapid characterisation of new isolates including full antibiogram and whole genome sequencing.
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-h6vhtk-0425a3
- Publication Source
- Find A Tender Service
- Latest Notice
- https://www.find-tender.service.gov.uk/Notice/003875-2024
- Current Stage
- Award
- All Stages
- Award
Procurement Classification
- Notice Type
- Award Notice
- Procurement Type
- Standard
- Procurement Category
- Services
- Procurement Method
- Limited
- Procurement Method Details
- Award procedure without prior publication of a call for competition
- Tender Suitability
- Not specified
- Awardee Scale
- Large
Common Procurement Vocabulary (CPV)
- CPV Divisions
73 - Research and development services and related consultancy services
-
- CPV Codes
73200000 - Research and development consultancy services
Notice Value(s)
- Tender Value
- Not specified
- Lots Value
- Not specified
- Awards Value
- Not specified
- Contracts Value
- £695,718 £500K-£1M
Notice Dates
- Publication Date
- 6 Feb 20242 years ago
- Submission Deadline
- Not specified
- Future Notice Date
- Not specified
- Award Date
- 29 Nov 20232 years ago
- Contract Period
- Not specified - Not specified
- Recurrence
- Not specified
Notice Status
- Tender Status
- Complete
- Lots Status
- Cancelled
- Awards Status
- Active
- Contracts Status
- Active
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- MEDICINES DISCOVERY CATAPULT SERVICES LIMITED
- Additional Buyers
- Contact Name
- Not specified
- Contact Email
- procurement@md.catapult.org.uk
- Contact Phone
- Not specified
Buyer Location
- Locality
- MACCLESFIELD
- Postcode
- SK10 4ZF
- Post Town
- Stockport
- Country
- England
-
- Major Region (ITL 1)
- TLD North West (England)
- Basic Region (ITL 2)
- TLD6 Cheshire
- Small Region (ITL 3)
- TLD62 Cheshire East
- Delivery Location
- Not specified
-
- Local Authority
- Cheshire East
- Electoral Ward
- Chelford
- Westminster Constituency
- Tatton
Further Information
Notice URLs
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-h6vhtk-0425a3-2024-02-06T13:38:53Z",
"date": "2024-02-06T13:38:53Z",
"ocid": "ocds-h6vhtk-0425a3",
"initiationType": "tender",
"tender": {
"id": "ocds-h6vhtk-0425a3",
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"title": "A multi-drug resistant pathogen reference strain and clinical isolate collection",
"status": "complete",
"classification": {
"scheme": "CPV",
"id": "73200000",
"description": "Research and development consultancy services"
},
"mainProcurementCategory": "services",
"description": "A multi-drug resistant pathogen reference strain and clinical isolate collection representative of pathogens and resistance mechanisms directly aligned to the PACE first funding call that can be used by the provider to generate antimicrobial susceptibility data across PACE-funded projects and that can be made available to PACE awardees for onward project progression. Continued expansion and characterisation of the strain and isolate collection to ensure it remains reflective of contemporary and genomically diverse multi-drug resistant and epidemic lineages of target pathogens (~20-30 strains) across E. coli, K. pneumoniae, P. aeruginosa, A. baumannii and S. aureus. This expanded collection will be made available for antimicrobial susceptibility testing (AST) across PACE-funded projects and the wider AMR community.",
"lots": [
{
"id": "1",
"description": "The UKHSA are well positioned to provide the services required by PACE for PACE portfolio funded projects and the wider AMR community. This will include but not be limited to the following: AST against a well characterised (including phenotypically, whole-genome sequenced with full antibiogram data) set of isolates and strains directly relevant to the PACE funding call, and; AST data delivered according to industry standards, and; Provided in an open-access environment, enabling PACE awardees to directly learn from and access the lab capability provided for onward studies, and; An opportunity to transfer specific isolates to PACE awardee labs for onward studies, and; The isolate bank will be evolved using the latest surveillance and national reference laboratory data on clinical isolates currently circulating nationally and internationally, and; UKHSA AMR labs then enable rapid characterisation of new isolates including full antibiogram and whole genome sequencing, and; A service model that can account for diverse needs of the PACE-funded projects as they arise i.e. variations to SOPs as required and ability to provide rapid surge capacity as and when needed.",
"hasOptions": false,
"awardCriteria": {
"criteria": [
{
"type": "price"
}
]
},
"status": "cancelled"
}
],
"items": [
{
"id": "1",
"deliveryAddresses": [
{
"region": "UK"
},
{
"region": "UK"
}
],
"relatedLot": "1",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "73200000",
"description": "Research and development consultancy services"
}
]
}
],
"procurementMethod": "limited",
"procurementMethodDetails": "Award procedure without prior publication of a call for competition",
"coveredBy": [
"GPA"
],
"procurementMethodRationaleClassifications": [
{
"scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL",
"id": "D_OUTSIDE_SCOPE",
"description": "The procurement falls outside the scope of application of the directive"
}
],
"procurementMethodRationale": "Following the voluntary ex ante transparency (VEAT) notice previously published, indicating that Medicines Discovery Catapult, intends to enter into a contract with the UK Health Security Agency (UKHSA) for a multi-drug resistant pathogen reference strain and clinical isolate collection without a call to competition in accordance with the Public Contracts Regulations 2015 ((32.2(b) ii), Medicines Discovery Catapult has now entered into the contract with UKHSA. The contract is directly aligned to the PACE (Pathways to Antimicrobial Clinical Efficacy) first funding call that can be used by the provider to generate antimicrobial susceptibility data across PACE-funded projects and that can be made available to PACE awardees for onward project progression and will allow continued expansion and characterisation of the strain and isolate collection to ensure it remains reflective of contemporary and genomically diverse multi-drug resistant and epidemic lineages of target pathogens (~20-30 strains) across E. coli, K. pneumoniae, P. aeruginosa, A. baumannii and S. aureus. This expanded collection will be made available for antimicrobial susceptibility testing (AST) across PACE-funded projects and the wider AMR community. The UKHSA maintains unique capabilities and assets that are part of the country's critical national infrastructure to support this aim, this includes; The English surveillance programme for antimicrobial utilisation and resistance (ESPAUR), which identifies emergence and trends in key resistance-causing pathogens. The AMRHAI (antimicrobial resistance and healthcare associated infections) national reference unit, part of the Bacteriology reference department (BRD) - a national and international laboratory reference centre for a bacterial infections. The isolate bank will be evolved using the latest surveillance and national reference laboratory data on clinical isolates currently circulating nationally and internationally and; UKHSA AMR labs then enable rapid characterisation of new isolates including full antibiogram and whole genome sequencing."
},
"awards": [
{
"id": "036804-2023-1",
"relatedLots": [
"1"
],
"status": "active",
"suppliers": [
{
"id": "GB-FTS-100677",
"name": "UK Health Security Agency"
}
]
},
{
"id": "003875-2024-1",
"relatedLots": [
"1"
],
"status": "active",
"suppliers": [
{
"id": "GB-FTS-104454",
"name": "UK Health Security Agency"
}
]
}
],
"parties": [
{
"id": "GB-COH-09928547",
"name": "MEDICINES DISCOVERY CATAPULT SERVICES LIMITED",
"identifier": {
"legalName": "MEDICINES DISCOVERY CATAPULT SERVICES LIMITED",
"id": "09928547",
"scheme": "GB-COH"
},
"address": {
"streetAddress": "Block 35g Mereside,Alderley Park",
"locality": "MACCLESFIELD",
"region": "UKD62",
"postalCode": "SK10 4ZF",
"countryName": "United Kingdom"
},
"contactPoint": {
"email": "procurement@md.catapult.org.uk"
},
"roles": [
"buyer"
],
"details": {
"url": "https://md.catapult.org.uk/",
"classifications": [
{
"scheme": "TED_CA_TYPE",
"description": "Drug Discovery / Health"
},
{
"scheme": "COFOG",
"description": "Drug Discovery / Health"
}
]
}
},
{
"id": "GB-FTS-100677",
"name": "UK Health Security Agency",
"identifier": {
"legalName": "UK Health Security Agency",
"noIdentifierRationale": "notOnAnyRegister"
},
"address": {
"locality": "London",
"region": "UK",
"postalCode": "E14 4PU",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-100678",
"name": "Medicines Discovery Catapult",
"identifier": {
"legalName": "Medicines Discovery Catapult"
},
"address": {
"locality": "Macclesfield",
"postalCode": "SK10 4ZF",
"countryName": "United Kingdom"
},
"roles": [
"reviewBody"
]
},
{
"id": "GB-FTS-104454",
"name": "UK Health Security Agency",
"identifier": {
"legalName": "UK Health Security Agency",
"noIdentifierRationale": "notOnAnyRegister"
},
"address": {
"locality": "Salisbury",
"region": "UK",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
}
],
"buyer": {
"id": "GB-COH-09928547",
"name": "MEDICINES DISCOVERY CATAPULT SERVICES LIMITED"
},
"contracts": [
{
"id": "036804-2023-1",
"awardID": "036804-2023-1",
"status": "active",
"value": {
"amount": 695718,
"currency": "GBP"
},
"dateSigned": "2023-11-29T00:00:00Z"
},
{
"id": "003875-2024-1",
"awardID": "003875-2024-1",
"status": "active",
"value": {
"amount": 695718,
"currency": "GBP"
},
"dateSigned": "2024-01-02T00:00:00Z"
}
],
"language": "en",
"bids": {
"statistics": [
{
"id": "1",
"measure": "bids",
"relatedLot": "1",
"value": 1
}
]
}
}